Rimonabant-mediated changes in intestinal lipid metabolism and improved renal vascular dysfunction in the JCR:LA-cp rat model of prediabetic metabolic syndrome (Q43052194)

From Wikidata

Jump to navigation Jump to search

scientific article published on 27 May 2010

Language	Label	Description	Also known as
English	Rimonabant-mediated changes in intestinal lipid metabolism and improved renal vascular dysfunction in the JCR:LA-cp rat model of prediabetic metabolic syndrome	scientific article published on 27 May 2010

Statements

scholarly article

1 reference

Europe PubMed Central

13 November 2017

Rimonabant-mediated changes in intestinal lipid metabolism and improved renal vascular dysfunction in the JCR:LA-cp rat model of prediabetic metabolic syndrome (English)

1 reference

Europe PubMed Central

13 November 2017

metabolic syndrome

1 reference

based on heuristic

inferred from title

author name string

James C Russell

1

1 reference

Europe PubMed Central

13 November 2017

Sandra E Kelly

2

1 reference

Europe PubMed Central

13 November 2017

Abdoulaye Diane

3

1 reference

Europe PubMed Central

13 November 2017

Ye Wang

4

1 reference

Europe PubMed Central

13 November 2017

Rabban Mangat

5

1 reference

Europe PubMed Central

13 November 2017

Susan Novak

6

1 reference

Europe PubMed Central

13 November 2017

Donna F Vine

7

1 reference

Europe PubMed Central

13 November 2017

Spencer D Proctor

8

1 reference

Europe PubMed Central

13 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

27 May 2010

1 reference

Europe PubMed Central

13 November 2017

American Journal of Physiology - Gastrointestinal and Liver Physiology

1 reference

Europe PubMed Central

13 November 2017

299

1 reference

Europe PubMed Central

13 November 2017

G507-16

1 reference

Europe PubMed Central

13 November 2017

2

1 reference

Europe PubMed Central

13 November 2017

The retardation of vasculopathy induced by attenuation of insulin resistance in the corpulent JCR:LA-cp rat is reflected by decreased vascular smooth muscle cell proliferation in vivo.

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00173.2010

21 January 2018

Rimonabant: just an antiobesity drug? Current evidence on its pleiotropic effects.

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00173.2010

21 January 2018

Animal models of insulin resistance and cardiovascular disease: some therapeutic approaches using JCR:LA-cp rat.

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00173.2010

21 January 2018

Rimonabant: the first therapeutically relevant cannabinoid antagonist

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00173.2010

21 January 2018

Anorectics on trial: a half century of federal regulation of prescription appetite suppressants

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00173.2010

21 January 2018

Acute phase proteins in atherosclerosis (acute coronary syndrome).

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00173.2010

21 January 2018

Enzyme changes in neonatal skeletal muscle: effect of thyroid deficiency

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00173.2010

21 January 2018

Hyperinsulinemia as an independent risk factor for ischemic heart disease.

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00173.2010

21 January 2018

Effect of rimonabant on the high-triglyceride/ low-HDL-cholesterol dyslipidemia, intraabdominal adiposity, and liver fat: the ADAGIO-Lipids trial

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00173.2010

21 January 2018

Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the community.

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00173.2010

21 January 2018

Rimonabant in rats with a metabolic syndrome: good news after the depression.

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00173.2010

21 January 2018

Monocyte chemoattractant protein-1--a major contributor to the inflammatory process associated with diabetes

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00173.2010

21 January 2018

The CB1 antagonist rimonabant decreases insulin hypersecretion in rat pancreatic islets

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00173.2010

21 January 2018

Dietary supplementation of n-3 PUFA reduces weight gain and improves postprandial lipaemia and the associated inflammatory response in the obese JCR:LA-cp rat.

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00173.2010

21 January 2018

Remarkable increase of apolipoprotein B48 level in diabetic patients with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00173.2010

21 January 2018

Genes, environment and Oji-Cree type 2 diabetes

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00173.2010

21 January 2018

Aldosterone and TGF-beta1 synergistically increase PAI-1 and decrease matrix degradation in rat renal mesangial and fibroblast cells

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00173.2010

21 January 2018

PAI-1 as a target in kidney disease

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00173.2010

21 January 2018

Peripheral endocannabinoid dysregulation in obesity: relation to intestinal motility and energy processing induced by food deprivation and re-feeding

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00173.2010

21 January 2018

Cannabinoids and the gut: new developments and emerging concepts

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00173.2010

21 January 2018

Blockade of cannabinoid CB1 receptors improves renal function, metabolic profile, and increased survival of obese Zucker rats.

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00173.2010

21 January 2018

Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lep(ob)/Lep(ob) mice

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00173.2010

21 January 2018

Chylomicron and apoB48 metabolism in the JCR:LA corpulent rat, a model for the metabolic syndrome.

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00173.2010

21 January 2018

Vascular wall function in insulin-resistant JCR:LA-cp rats: role of male and female sex.

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00173.2010

21 January 2018

How many sites of action for endocannabinoids to control energy metabolism?

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00173.2010

21 January 2018

Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00173.2010

21 January 2018

The anti-obesity effect of rimonabant is associated with an improved serum lipid profile

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00173.2010

21 January 2018

Synergistic effects of conjugated linoleic acid and chromium picolinate improve vascular function and renal pathophysiology in the insulin-resistant JCR:LA-cp rat.

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00173.2010

21 January 2018

Small animal models of cardiovascular disease: tools for the study of the roles of metabolic syndrome, dyslipidemia, and atherosclerosis

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00173.2010

21 January 2018

Arterial permeability and efflux of apolipoprotein B-containing lipoproteins assessed by in situ perfusion and three-dimensional quantitative confocal microscopy.

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00173.2010

21 January 2018

Vasculopathy and insulin resistance in the JCR:LA-cp rat.

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00173.2010

21 January 2018

The link between abdominal obesity, metabolic syndrome and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00173.2010

21 January 2018

Inhibition of atherosclerosis and myocardial lesions in the JCR:LA-cp rat by beta, beta'-tetramethylhexadecanedioic acid (MEDICA 16).

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00173.2010

21 January 2018

Improvement of insulin sensitivity and cardiovascular outcomes in the JCR:LA-cp rat by D-fenfluramine.

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00173.2010

21 January 2018

Inhibition of myocardial lesions in the JCR:LA-corpulent rat by captopril.

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00173.2010

21 January 2018

Glucose tolerance and insulin resistance in the JCR:LA-corpulent rat: effect of miglitol (Bay m1099).

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00173.2010

21 January 2018

Insulin-sensitizing and cardiovascular effects of the sodium-hydrogen exchange inhibitor, cariporide, in the JCR: LA-cp rat and db/db mouse

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00173.2010

21 January 2018

Effects of LY117018 and the estrogen analogue, 17alpha-ethinylestradiol, on vascular reactivity, platelet aggregation, and lipid metabolism in the insulin-resistant JCR:LA-cp male rat: role of nitric oxide

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00173.2010

21 January 2018

Increased insulin sensitivity and reduced micro and macro vascular disease induced by 2-deoxy-D-glucose during metabolic syndrome in obese JCR: LA-cp rats.

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00173.2010

21 January 2018

Chronic vasopeptidase inhibition normalizes diabetic endothelial dysfunction

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00173.2010

21 January 2018

Anti-MCP-1 gene therapy inhibits vascular smooth muscle cells proliferation and attenuates vein graft thickening both in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00173.2010

21 January 2018

Fibrinolysis and atherogenesis in the JCR:LA-cp rat in relation to insulin and triglyceride concentrations in blood.

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00173.2010

21 January 2018

Association between circulating monocyte chemoattractant protein-1 and urinary albumin excretion in nonobese Type 2 diabetic patients.

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00173.2010

21 January 2018

Regulation of C/EBPdelta-dependent transactivation by histone deacetylases in intestinal epithelial cells

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00173.2010

21 January 2018

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00173.2010

21 January 2018

Impaired postprandial apolipoprotein-B48 metabolism in the obese, insulin-resistant JCR:LA-cp rat: increased atherogenicity for the metabolic syndrome.

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00173.2010

21 January 2018

Intestinal lipid transport and chylomicron production: possible links to exacerbated atherogenesis in a rodent model of the metabolic syndrome.

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00173.2010

21 January 2018

Rimonabant: endocannabinoid inhibition for the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00173.2010

21 January 2018

Phenotype of the obese Koletsky (f) rat due to Tyr763Stop mutation in the extracellular domain of the leptin receptor (Lepr): evidence for deficient plasma-to-CSF transport of leptin in both the Zucker and Koletsky obese rat.

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00173.2010

21 January 2018

Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00173.2010

21 January 2018

Identifiers

10.1152/AJPGI.00173.2010

1 reference

Europe PubMed Central

13 November 2017

1 reference

Europe PubMed Central

13 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43052194&oldid=1978793658"